A real-world study on Clofarabine and Cytarabine combination in patients with relapsed/refractory acute myeloid leukemia. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 11, n. 1, p. e2019032, 2019. DOI: 10.4084/mjhid.2019.032. Disponível em: https://www.mjhid.org/mjhid/article/view/2019.032. Acesso em: 15 jun. 2026.